{"mainPropery":{"diseaseId":1107,"diseaseName":"Cardiomyopathy due to anthracyclines","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1107/cardiomyopathy-due-to-anthracyclines","synonyms":[],"synonyms-with-source":[],"identifiers":[]},"diseaseCategories":[],"organizations":[],"resource descriptions":[],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":389,"genericName":"Dexrazoxane","tradeName":"Zinecard (injection)","tradeLink":"http://www.pfizer.com/products/rx/rx_product_zinecard.jsp","manufacturer":"Pfizer","sponsor":"Pharmacia & Upjohn","indication":"Cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative dose of 300mg/m2.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?regno=024584096","medlinePlusLink":"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a609010.html"}],"EncodedName":"Cardiomyopathy_due_to_anthracyclines"}